CLEC3A, MMP7, and LCN2 as novel markers for predicting recurrence in resected G1 and G2 pancreatic neuroendocrine tumors

Although the postoperative recurrence rate for pancreatic neuroendocrine tumors (PNETs) is reported to be 13.5%‐30%, the paucity of valuable biomarkers to predict recurrence poses a problem for the early detection of relapse. Hence, this study aimed to identify new biomarkers to predict the recurren...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Med
Main Authors: Miki, Masami, Oono, Takamasa, Fujimori, Nao, Takaoka, Takehiro, Kawabe, Ken, Miyasaka, Yoshihiro, Ohtsuka, Takao, Saito, Daisuke, Nakamura, Masafumi, Ohkawa, Yasuyuki, Oda, Yoshinao, Suyama, Mikita, Ito, Tetsuhide, Ogawa, Yoshihiro
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2019
Subjects:
Clinical Cancer Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6639196/
https://ncbi.nlm.nih.gov/pubmed/31129920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2232
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items